Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The kidney in essential hypertension.

A Losito1

  • 1Servizio di Nefrologia e Dialisi, Policlinico, Perugia, Italy.

Comprehensive Therapy
|August 1, 1989
PubMed
Summary

Modern antihypertensive medications effectively lower blood pressure, protecting kidney function and delaying disease progression. This approach prevents further organ damage caused by hypertension.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Guidelines compared: a new series].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2009
Same author

[SIN ECM activity 2007-2008 and program 2009].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2009
Same author

[Giovanni Gigli. The Nephrological School of Pisa from Tuscany to Umbria].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2008
Same author

[Historical Archives of Italian Nephrology. "Le Giornate Mediche Triestine del 1952" the first nephrological international meeting held in Italy].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2006
Same author

3 R study: renal outcome in renal ischemia: revascularisation or medical treatment.

Journal of nephrology·2000
Same author

Angiotensin-converting enzyme gene I/D polymorphism and carotid artery disease in renovascular hypertension.

American journal of hypertension·2000

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Hypertension is a leading cause of chronic kidney disease.
  • Hypertensive organ damage, particularly to the kidneys, often leads to irreversible decline.
  • Antihypertensive therapies aim to manage blood pressure and mitigate organ damage.

Purpose of the Study:

  • To evaluate the impact of current antihypertensive agents on renal function in hypertensive patients.
  • To determine if blood pressure reduction can be achieved without adverse effects on kidney health.
  • To assess the potential of these agents in delaying the progression of kidney disease.

Main Methods:

  • Review of clinical data on patients treated with modern antihypertensive agents.
  • Analysis of blood pressure readings and renal function markers (e.g., glomerular filtration rate, albuminuria).
  • Comparative analysis of renal outcomes in treated versus untreated or inadequately treated hypertensive individuals.

Main Results:

  • Current antihypertensive agents effectively reduce blood pressure.
  • Treatment demonstrates a capacity to improve or preserve renal function.
  • The decline in renal function typically associated with hypertensive kidney damage is significantly delayed.

Conclusions:

  • Modern antihypertensive pharmacotherapy offers a viable strategy for managing hypertension without compromising kidney health.
  • These medications play a crucial role in preserving renal function and slowing the progression of hypertensive nephropathy.
  • Effective blood pressure control is key to preventing long-term kidney damage in hypertensive individuals.

Related Experiment Videos